Top Markets
#1 ADO Protocol ADO Protocol +335.42%
#2 GoPlus Security GoPlus Security +41.13%
#3 Starpower Starpower +35.26%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.65%
#6 The Black Bull The Black Bull +15.87%
#7 Nockchain Nockchain +14.43%
#8 Provenance Blockchain Provenance Blockchain +12.81%
#9 Casper Network Casper Network +12.45%
#10 DMT-NAT DMT-NAT +11.83%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rangering i aksjer #33331
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Aksjekurs
$0.12476927
Markedsverdi
$7.86M
Endring (1 dag)
0.00%
Endring (1 år)
-19.80%
Land
CA
Handel Marvel Biosciences Corp. (MRVL)

Kategori

Healthcare
P/S-forhold for Marvel Biosciences Corp. (MRVL)
P/S-forhold per 2026 TTM: 0
Ifølge Marvel Biosciences Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Marvel Biosciences Corp. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE